NEURO-COVID-19: Neuroradiolological Analysis of COVID-19 Patients
Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Unknown status
CT.gov ID
NCT04368390
Collaborator
(none)
100
1
11.9
8.4
Study Details
Study Description
Brief Summary
To describe the radiological presentation of brain abnormalities in COVID-19 + patients
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
100 participants
Observational Model:
Case-Only
Time Perspective:
Other
Official Title:
Imaging Analysis of COVID-19 + Patients With Abnormal Neurological Examination
Actual Study Start Date
:
Apr 3, 2020
Anticipated Primary Completion Date
:
Apr 1, 2021
Anticipated Study Completion Date
:
Apr 1, 2021
Outcome Measures
Primary Outcome Measures
- Neuroradiological analysis of patients brain MRI [1 year]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
-
Adults
-
COVID-19 +
-
Abnormal neurological examination
-
who underwent a brain MRI
Exclusion Criteria:
-
No participation agreement
-
Non COVID-19 patients
-
Patients COVID-19 + without neurological abnormality or without MRI examination
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Service d'Imagerie 2 - Neuroradiologie | Strasbourg | France | 67091 |
Sponsors and Collaborators
- University Hospital, Strasbourg, France
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT04368390
Other Study ID Numbers:
- 7759
First Posted:
Apr 29, 2020
Last Update Posted:
Dec 24, 2020
Last Verified:
Apr 1, 2020